10.1515/jbcpp-2014-0105 4 AdeyemiO
Wang M, Pu Z, Zhang J, Wang P, Chen Y, Zhu Y, et al
The dose of BAY11-7082 was chosen based on our preliminary results of dose response, which showed that 10 M BAY11-7082 significantly increased the number of surviving SGNs after cisplatin damage in vitro (Supplementary Figure 2)
Chang S, Ren G, Steiner RD, Merkens L, Roullet JB, Korade Z, et al
Itulah mengapa banyak produsen saat ini tidak lagi hanya fokus pada peningkatan kandungan, tetapi lebih banyak berinvestasi pada kualitas bahan baku, bentuk bahan aktif, dan teknologi manufaktur untuk membantu melindungi Glutathione selama penyerapan
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach